Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC

Delayed Quote. Delayed  - 05/27 09:59:58 pm
99.43 USD   -0.64%
05/26 Anacor received rival bid before Pfizer deal - filing
05/23 ACQUISITION OF : ANAC) Under Investigation for Investors
05/21 Brodsky & Smith, LLC Announces Investigation of The Board of Dire..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
99.39(c) 99.43(c) 99.24(c) 100.07(c) 99.43(c) Last
2 138 563 3 330 432 5 719 833 4 544 137 2 190 840 Volume
-0.27% +0.04% -0.19% +0.84% -0.64% Change
More quotes
Financials ($)
Sales 2016 81,7 M
EBIT 2016 -64,2 M
Net income 2016 -69,3 M
Debt 2016 -
Yield 2016 -
Sales 2017 242 M
EBIT 2017 -9,38 M
Net income 2017 -6,33 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 1 057,77
Capi. / Sales 2016 55,2x
Capi. / Sales 2017 18,7x
Capitalization 4 511 M
More Financials
Company
Anacor Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered following compounds that are currently in development including... 
More about the company
Surperformance© ratings of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ANACOR PHARMACEUTICALS INC
05/26 Anacor received rival bid before Pfizer deal - filing
05/23 ACQUISITION OF ANACOR PHARMACEUTICAL : ANAC) Under Investigation for Investors
05/21 Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
05/20 Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor..
05/20 ANACOR SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation of ..
05/20 Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
05/19 ANACOR PHARMACEUTICALS : Reports First Quarter 2016 Financial Results
05/19 Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the S..
05/18 ANACOR PHARMACEUTICALS SHAREHOLDER A : Former SEC Attorney Willie Briscoe and Po..
05/18 RYAN & MANISKAS, LLP : Announces Investigation of Anacor Pharmaceuticals, Inc.
More news
Sector news : Biotechnology & Medical Research - NEC
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/26 Apple's Next Moves? Hints From M&A Talks
05/24 In-House Projects An Ever-Thinner Slice Of Sales For Big Pharma
05/23 BIOTECH FORUM DAILY DIGEST : Can Biotech Rally For The Second Week In A Row? New..
05/20 BIOTECH FORUM DAILY DIGEST : Spotlight On Xenon. Biotech Posts Strong Week. Acad..
05/20 Healthcare ratings roundup
Advertisement
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Technical analysis trends ANACOR PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions